Bbva Compass Bancshares Inc. Has $2.30 Million Holdings in Stryker Co. (SYK)

Bbva Compass Bancshares Inc. raised its stake in Stryker Co. (NYSE:SYK) by 1.1% during the 1st quarter, Holdings Channel reports. The firm owned 11,663 shares of the medical technology company’s stock after acquiring an additional 123 shares during the period. Bbva Compass Bancshares Inc.’s holdings in Stryker were worth $2,304,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently made changes to their positions in SYK. Welch Group LLC boosted its stake in shares of Stryker by 1.5% in the first quarter. Welch Group LLC now owns 3,774 shares of the medical technology company’s stock valued at $745,000 after buying an additional 54 shares in the last quarter. Independence Bank of Kentucky boosted its stake in shares of Stryker by 4.9% in the first quarter. Independence Bank of Kentucky now owns 1,180 shares of the medical technology company’s stock valued at $233,000 after buying an additional 55 shares in the last quarter. Benedict Financial Advisors Inc. boosted its stake in shares of Stryker by 1.1% in the first quarter. Benedict Financial Advisors Inc. now owns 5,235 shares of the medical technology company’s stock valued at $1,034,000 after buying an additional 57 shares in the last quarter. 1ST Source Bank boosted its stake in shares of Stryker by 3.5% in the first quarter. 1ST Source Bank now owns 1,760 shares of the medical technology company’s stock valued at $348,000 after buying an additional 60 shares in the last quarter. Finally, Westside Investment Management Inc. boosted its stake in shares of Stryker by 38.7% in the fourth quarter. Westside Investment Management Inc. now owns 233 shares of the medical technology company’s stock valued at $37,000 after buying an additional 65 shares in the last quarter. Institutional investors own 74.68% of the company’s stock.

In other news, Chairman Kevin Lobo sold 41,750 shares of the business’s stock in a transaction on Monday, March 25th. The stock was sold at an average price of $194.11, for a total value of $8,104,092.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Glenn S. Boehnlein sold 2,700 shares of the business’s stock in a transaction on Wednesday, May 8th. The stock was sold at an average price of $188.21, for a total value of $508,167.00. Following the completion of the transaction, the chief financial officer now directly owns 23,333 shares of the company’s stock, valued at $4,391,503.93. The disclosure for this sale can be found here. Over the last three months, insiders sold 111,550 shares of company stock valued at $21,374,171. Insiders own 7.20% of the company’s stock.



A number of analysts recently weighed in on SYK shares. Cantor Fitzgerald restated a “neutral” rating on shares of Stryker in a research note on Friday, January 18th. Canaccord Genuity boosted their target price on Stryker from $185.00 to $190.00 and gave the stock a “buy” rating in a research report on Wednesday, January 30th. Credit Suisse Group upgraded Stryker to an “outperform” rating in a research report on Thursday, January 31st. SunTrust Banks boosted their target price on Stryker to $205.00 and gave the stock a “positive” rating in a research report on Monday, February 4th. Finally, Zacks Investment Research upgraded Stryker from a “hold” rating to a “buy” rating and set a $199.00 target price on the stock in a research report on Monday, February 4th. Six analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $196.89.

NYSE SYK opened at $184.20 on Tuesday. Stryker Co. has a fifty-two week low of $144.75 and a fifty-two week high of $199.85. The firm has a market capitalization of $70.15 billion, a PE ratio of 25.20, a P/E/G ratio of 2.29 and a beta of 0.84. The company has a quick ratio of 1.30, a current ratio of 2.12 and a debt-to-equity ratio of 0.68.

Stryker (NYSE:SYK) last released its quarterly earnings results on Tuesday, April 23rd. The medical technology company reported $1.88 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.84 by $0.04. Stryker had a return on equity of 26.72% and a net margin of 25.38%. The company had revenue of $3.52 billion during the quarter, compared to analysts’ expectations of $3.51 billion. During the same period in the previous year, the firm posted $1.68 earnings per share. The business’s revenue for the quarter was up 8.5% compared to the same quarter last year. As a group, research analysts predict that Stryker Co. will post 8.15 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 31st. Stockholders of record on Friday, June 28th will be issued a $0.52 dividend. The ex-dividend date of this dividend is Thursday, June 27th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 1.13%. Stryker’s dividend payout ratio (DPR) is 28.45%.

TRADEMARK VIOLATION NOTICE: This piece was originally published by Dakota Financial News and is the sole property of of Dakota Financial News. If you are accessing this piece on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this piece can be viewed at https://dakotafinancialnews.com/2019/05/14/bbva-compass-bancshares-inc-has-2-30-million-holdings-in-stryker-co-syk.html.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.

Featured Story: What are the benefits of investing in REITs?

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.